Similar Posts
Zydus Lifesciences shares jump 6% on buyback buzz; co announces $166 mn Assertio acquisition
Shares of Zydus Lifesciences jumped around 6% after the company announced that its board of directors will meet on May 19 (Tuesday) to consider a buyback of shares. The pharma company also announced the acquisition of US-based cancer drug-maker Assertio for $166.4 million. Zydus Lifesciences shares climbed to an intraday high of Rs 993.80 on…
Why Private Capex won’t pick up
Source : Noah Smith Source link
Negative Breakout: 4 stocks cross below their 200 DMAs – Downside Ahead
In the NSE list of stocks with a market cap over Rs 1000 crore, four stocks’ close prices crossed below their 200 DMA (Daily Moving Averages) on April 11, according to stockedge.com’s technical scan data. Trading below the 200 DMA is considered a negative signal because it indicates that the stock’s price is below its…
A real estate company defying the odds? Compass just hit a 52-week high—here’s why investors are buzzing about its next move 🔥
Compass, Inc. (NYSE: COMP) has recently captured investor attention with a significant stock surge, reaching a 52-week high of $7.06. This upward momentum reflects the company’s strong financial performance, strategic initiatives, and positive market outlook. This article A real estate company defying the odds? Compass just hit a 52-week high—here’s why investors are buzzing about…
